Lifecore Biomedical, Inc. (LFCR)

Last Closing Price: 6.28 (2023-02-01)

Company Description

Lifecore Biomedical Inc. is a fully integrated contract development and manufacturing organization which offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. Lifecore Biomedical Inc., formerly known as Landec Corporation, is based in CHASKA, Minn.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $185.79M
Net Income (Most Recent Fiscal Year) $-97.43M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 0.68
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.92
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 1.76
Pre-Tax Margin (Trailing 12 Months) -20.04%
Net Margin (Trailing 12 Months) -36.49%
Return on Equity (Trailing 12 Months) -16.79%
Return on Assets (Trailing 12 Months) -6.38%
Current Ratio (Most Recent Fiscal Quarter) 1.40
Quick Ratio (Most Recent Fiscal Quarter) 0.63
Debt to Common Equity (Most Recent Fiscal Quarter) 0.99
Inventory Turnover (Trailing 12 Months) 1.99
Book Value per Share (Most Recent Fiscal Quarter) $3.66
Earnings per Share (Most Recent Fiscal Quarter) $-0.32
Earnings per Share (Most Recent Fiscal Year) $0.90
Diluted Earnings per Share (Trailing 12 Months) $-3.38
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 29.60M
Free Float 25.27M
Market Capitalization $185.86M
Average Volume (Last 20 Days) 0.11M
Beta (Past 60 Months) 1.09
Percentage Held By Insiders (Latest Annual Proxy Report) 14.61%
Percentage Held By Institutions (Latest 13F Reports) --
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%